Two-stage (any method) and multiplicity [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2011-10-30 19:26 (4982 d 04:26 ago) – Posting: # 7560
Views: 8,325

Dear HS,

❝ Opinions, ideas?


There are quite a few SPC's out there which state dose proportionality or dose linearity and where the originator as far as I know hasn't really done that fancy stuff but just administered a series of doses and checked AUC or Cmax or Cl. That's good enough isn't it.
At least for EU, I guess part of the story is to live with the BE-guideline's requirement "Assessment of linearity will consider whether differences in dose-adjusted AUC meet a criterion of ± 25%." which can be dealt with very simply.
Perhaps your angle is different and that where the complexity comes in? I am eager to hear.

Btw, in spite of the links to previous definitions and discussions I still think we need some useful definitions, preferably in guidelines. Cmax etc vs dose being a straight line, I am perfectly willing to call that linearity; Wikipedia does an excellent job at confusing readers.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
39 visitors (0 registered, 39 guests [including 8 identified bots]).
Forum time: 00:52 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5